Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00687479 · ClinicalTrials.gov registry record

Insulin Action During Pregnancy in Woman at High Risk for Gestational Diabetes

A clinical trial of Gestational Diabetes Mellitus, sponsored by Woman's.

Completed
Registry status
175
Enrollment target
1
Study location

NCT00687479 is a study of Gestational Diabetes Mellitus that has completed, run by Woman's. The registered enrollment target is 175 participants, below the 408-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00687479, a study of Gestational Diabetes Mellitus, has completed, sponsored by Woman's.

COMPLETED
Registry status
175 participants
Enrollment target
1
Study location

Study Summary

The project objective is to validate a new indirect estimate of insulin status in both pregnant African-American women and Caucasian women in southern Louisiana who are at risk for gestational diabetes mellitus. There are racial differences in carbohydrate metabolism that are potentially linked to complications during pregnancy and to increased risks of obesity and diabetes in later life. The investigators will explore the use of indexes of insulin status to identify the metabolic risk profile of pregnant women which may vary by race. Understanding whether there are differences which vary by race may influence clinical screening and treatment of pregnant women.

Study Locations (1)

Louisiana

  • Woman's Hospital Pathology Laboratory - Baton Rouge

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2006-01
Est. Completion 2009-12

Sponsor

Woman's

17 total trials

What the Registry Record Tells You About NCT00687479

The ClinicalTrials.gov registry entry for NCT00687479 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 408-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (57% lower). The listed sponsor is Woman's, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.

NCT00687479 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT00687479 about?

NCT00687479 is a clinical study titled "Insulin Action During Pregnancy in Woman at High Risk for Gestational Diabetes". The project objective is to validate a new indirect estimate of insulin status in both pregnant African-American women and Caucasian women in southern Louisiana who are at risk for gestational diabetes mellitus. There are racial differences in carbohydrate metabolism that are potentially linked to c...

What is the current status of trial NCT00687479?

This trial is currently completed. The enrollment target is 175 participants. The study started on 2006-01. Estimated completion is 2009-12.

What conditions does trial NCT00687479 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus.

Who is sponsoring clinical trial NCT00687479?

This trial is sponsored by Woman's, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00687479 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.